These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27062904)

  • 1. Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis.
    Stonebraker JR; Ooi CY; Pace RG; Corvol H; Knowles MR; Durie PR; Ling SC
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1207-1215.e3. PubMed ID: 27062904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERPINA1 Z allele is associated with cystic fibrosis liver disease.
    Boëlle PY; Debray D; Guillot L; Corvol H;
    Genet Med; 2019 Sep; 21(9):2151-2155. PubMed ID: 30739910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.
    Nash KL; Allison ME; McKeon D; Lomas DJ; Haworth CS; Bilton D; Alexander GJ
    J Cyst Fibros; 2008 May; 7(3):252-7. PubMed ID: 18042441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study.
    Leung DH; Ye W; Schwarzenberg SJ; Freeman AJ; Palermo JJ; Weymann A; Alonso EM; Karnsakul WW; Murray KF; Stoll JM; Huang S; Karmazyn B; Masand P; Magee JC; Alazraki AL; Towbin AJ; Nicholas JL; Green N; Otto RK; Siegel MJ; Ling SC; Navarro OM; Harned RK; Narkewicz MR; Molleston JP;
    J Cyst Fibros; 2023 Mar; 22(2):248-255. PubMed ID: 35985930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modifiers of liver disease in cystic fibrosis.
    Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
    JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease.
    Aqul A; Jonas MM; Harney S; Raza R; Sawicki GS; Mitchell PD; Fawaz R
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):505-511. PubMed ID: 27782957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension.
    Wu H; Vu M; Dhingra S; Ackah R; Goss JA; Rana A; Quintanilla N; Patel K; Leung DH
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2134-2136. PubMed ID: 30404037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis-associated liver disease in children.
    Wasuwanich P; Karnsakul W
    Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
    Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T
    Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Algorithm for the Integration of Ultrasound Into Cystic Fibrosis Liver Disease Screening.
    Sellers ZM; Lee LW; Barth RA; Milla C
    J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):404-410. PubMed ID: 31181020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
    Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
    Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation for cystic fibrosis: outcome following early liver transplantation.
    Milkiewicz P; Skiba G; Kelly D; Weller P; Bonser R; Gur U; Mirza D; Buckels J; Stableforth D; Elias E
    J Gastroenterol Hepatol; 2002 Feb; 17(2):208-13. PubMed ID: 11966953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy.
    Sakhuja S; Staples HM; Minard CG; Ramm LE; Lewindon PJ; Ramm GA; Leung DH
    Liver Int; 2023 Jun; 43(6):1277-1286. PubMed ID: 37035868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    Klotter V; Gunchick C; Siemers E; Rath T; Hudel H; Naehrlich L; Roderfeld M; Roeb E
    PLoS One; 2017; 12(6):e0178784. PubMed ID: 28575039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic radiation force impulse (ARFI) imaging with Virtual Touch Tissue Quantification in liver disease associated with cystic fibrosis in children.
    Monti L; Manco M; Lo Zupone C; Latini A; D'Andrea ML; Alghisi F; Lucidi V; Tomà P; Bonomo L
    Radiol Med; 2012 Dec; 117(8):1408-18. PubMed ID: 22986694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
    ONeill JP; Clifford CS; Nolan NP; McCormick PA
    Ir J Med Sci; 2023 Aug; 192(4):1657-1660. PubMed ID: 36114932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cirrhosis and portal hypertension in cystic fibrosis.
    Fustik S
    Srp Arh Celok Lek; 2013; 141(11-12):764-9. PubMed ID: 24502094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.